JOIN SNO IN PHOENIX! The SNO annual meeting is the world’s largest neuro-oncology conference, attracting over 2400 researchers and clinician-scientists from more than 40 countries. Spanning all neuro-oncology disciplines, professions, ...
The premier international meeting featuring novel cancer therapeutics. Oct. 26-30, 2019 Hynes Convention Center Boston, Massachusetts Organizing Committee Cochairs Elizabeth M. Jaffee, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, ...
ABOUT THE ONCOLOGY 2019 Fearless commitment for a Cancer free world Hilaris Conferences warmly invite you to meet inspiring speakers and experts for the conference Oncology 2019 in Paris, France ...
The ESMO Congress is the appointment in Europe for clinicians, researchers, patient advocates, journalists and the pharmaceutical industry from all over the world to get together, learn about the latest ...
July 12, 2019 08:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today the appointment of Andrew Eisen, M.D., Ph.D. as ...
June 20, 2019 20:05 UTC ROCKVILLE, Md.--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today the promotion of Teri Heiland, Ph.D. to Chief Scientific Officer. ...
May 30, 2019 04:05 PM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at the China ...
ABOUT THE 5TH ANNUAL IMMUNO-ONCOLOGY FORUM Taking place on the first day of ASCO, the 5th Annual Immuno-Oncology BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient ...
Immunomic Therapeutics to Participate at Sachs’ 5th Annual Immuno-Oncology BD&L and Investment Forum
May 24, 2019 20:05 UTC ROCKVILLE, Md.--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at the 5th Annual Immuno-oncology ...
April 04, 2019 04:05 PM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. announced today that it will participate at the World Vaccine Congress Washington being held in Washington, D.C. ...
ITI will be sponsoring the World Vaccine and Immunotherapy Congress for the second year in a row. After an incredibly successful two years in San Diego, the World Vaccine and ...
The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world ...